US court invalidates key patent on J&J’s Zytiga
J&J to appeal decision.
X
US court invalidates key patent on J&J’s Zytiga
https://pharmaphorum.com/news/court-invalidates-key-patent-jjs-zytiga/
generic
Concordia hiked drug price by 6,000%, says UK watchdog
CMA provisionally finds Concordia overpriced thyroid drug.
Hikma in dispute with FDA over Advair generic
Hikma to give up date in Q1 next year.
Judge throws out Allergan patents, criticises Native American tribe deal
Federal court throws out patents on Restasis
Copaxone first on FDA’s list for faster complex generic approvals
Teva will attempt to block generic launch in courts
EU authorities accuse Teva of breaking competition rules
Teva accused of “pay for delay” deal with Cephalon.
FDA approves Adamis’ cheaper rival to EpiPen
Symjepi also smaller and more convenient.
EU probes Aspen price gouging allegations
Aspen pulled drugs from some countries that rejected price hikes, says EU.
